S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NYSE:RTO

Rentokil Initial (RTO) Stock Forecast, Price & News

$40.67
-0.18 (-0.44%)
(As of 06/7/2023 ET)
Compare
Today's Range
$40.66
▼
$41.12
50-Day Range
$35.16
▼
$40.85
52-Week Range
$24.85
▼
$41.12
Volume
116,963 shs
Average Volume
345,854 shs
Market Capitalization
$20.50 billion
P/E Ratio
N/A
Dividend Yield
1.38%
Price Target
$47.00
ProfileAnalyst RatingsChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Rentokil Initial MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
15.6% Upside
$47.00 Price Target
Short Interest
Healthy
0.14% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.42mentions of Rentokil Initial in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
16.15%
From $1.30 to $1.51 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Business Services Sector

208th out of 323 stocks

Disinfecting & Pest Control Services Industry

1st out of 1 stocks

See Top Rated MarketRank™ Stocks Here

RTO stock logo

About Rentokil Initial (NYSE:RTO) Stock

Rentokil Initial Plc engages in the provision of business support services. The firm's products and services protect people from pest-borne disease and the risks of poor hygiene. It operates through the following geographical segments: North America, Europe, UK and Sub-Saharan Africa, Asia and MENAT, and Pacific. The company was founded by Harold Maxwell-Lefroy on September 24, 1924 and is headquartered in Crawley, the United Kingdom.

Receive RTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rentokil Initial and its competitors with MarketBeat's FREE daily newsletter.

RTO Stock News Headlines

May 27, 2023 | finance.yahoo.com
RTO.L - Rentokil Initial plc
May 22, 2023 | americanbankingnews.com
Oppenheimer Increases Rentokil Initial (NYSE:RTO) Price Target to $47.00
June 7, 2023 | Behind the Markets (Ad)
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
May 18, 2023 | msn.com
Jefferies Reiterates Rentokil Initial (LSE:RTO) Buy Recommendation
April 28, 2023 | finance.yahoo.com
Directors’ Deals: Rentokil share sales pay Ransom
April 22, 2023 | msn.com
Barclays Reiterates Rentokil Initial (LSE:RTO) Overweight Recommendation
March 30, 2023 | americanbankingnews.com
Head to Head Analysis: Rentokil Initial (OTCMKTS:RTOKY) versus Rentokil Initial (NYSE:RTO)
March 29, 2023 | americanbankingnews.com
Head to Head Survey: Rentokil Initial (NYSE:RTO) vs. Rentokil Initial (OTCMKTS:RTOKY)
June 7, 2023 | Behind the Markets (Ad)
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
March 29, 2023 | americanbankingnews.com
Critical Analysis: Rentokil Initial (NYSE:RTO) vs. Rentokil Initial (OTCMKTS:RTOKY)
March 28, 2023 | americanbankingnews.com
Contrasting Rentokil Initial (NYSE:RTO) & Rentokil Initial (OTCMKTS:RTOKY)
March 27, 2023 | americanbankingnews.com
Contrasting Rentokil Initial (OTCMKTS:RTOKY) & Rentokil Initial (NYSE:RTO)
March 27, 2023 | americanbankingnews.com
Head to Head Contrast: Rentokil Initial (OTCMKTS:RTOKY) vs. Rentokil Initial (NYSE:RTO)
March 26, 2023 | americanbankingnews.com
Financial Analysis: Rentokil Initial (NYSE:RTO) & Rentokil Initial (OTCMKTS:RTOKY)
March 25, 2023 | americanbankingnews.com
Rentokil Initial plc Declares Semi-annual Dividend of $0.32 (NYSE:RTO)
March 23, 2023 | seekingalpha.com
Rentokil Initial plc: Business Is On Track To Grow Faster
March 22, 2023 | americanbankingnews.com
Rentokil Initial (NYSE:RTO) Rating Increased to Neutral at BNP Paribas
See More Headlines

RTO Price History

RTO Company Calendar

Ex-Dividend for 5/30 Dividend
4/10/2023
Dividend Payable
5/30/2023
Today
6/07/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Disinfecting & pest control services
Sub-Industry
N/A
Sector
Business Services
Current Symbol
NYSE:RTO
CUSIP
N/A
CIK
930157
Web
www.rentokil-initial.com
Phone
441293858000
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$47.00
High Stock Price Forecast
$47.00
Low Stock Price Forecast
$47.00
Forecasted Upside/Downside
+15.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
31.35
P/E Growth
2.39
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.87
Current Ratio
1.14
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$4.59 billion
Price / Sales
4.47
Cash Flow
$1.98 per share
Price / Cash Flow
20.61
Book Value
$10.06 per share
Price / Book
4.05

Miscellaneous

Outstanding Shares
504,010,000
Free Float
N/A
Market Cap
$20.54 billion
Optionable
Not Optionable
Beta
0.90

Key Executives

  • Andrew M. Ransom
    Chief Executive Officer & Executive Director
  • Brian Webb
    Group Director-Operations Excellence
  • Stuart Ingall-Tombs
    Chief Financial Officer & Director
  • Mark Purcell
    Chief Information Officer
  • Catherine Elizabeth Lynch
    Director-Group HR Strategy, Technology & Insight

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













RTO Stock - Frequently Asked Questions

Should I buy or sell Rentokil Initial stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rentokil Initial in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" RTO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RTO, but not buy additional shares or sell existing shares.
View RTO analyst ratings or view top-rated stocks.

What is Rentokil Initial's stock price forecast for 2023?

3 equities research analysts have issued 1-year price targets for Rentokil Initial's shares. Their RTO share price forecasts range from $47.00 to $47.00. On average, they anticipate the company's stock price to reach $47.00 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts price targets for RTO or view top-rated stocks among Wall Street analysts.

How have RTO shares performed in 2023?

Rentokil Initial's stock was trading at $30.81 on January 1st, 2023. Since then, RTO shares have increased by 32.3% and is now trading at $40.76.
View the best growth stocks for 2023 here.

How often does Rentokil Initial pay dividends? What is the dividend yield for Rentokil Initial?

Rentokil Initial declared a semi-annual dividend on Thursday, March 23rd. Shareholders of record on Tuesday, April 11th will be paid a dividend of $0.3169 per share on Tuesday, May 30th. This represents a yield of 0.8%. The ex-dividend date is Monday, April 10th.
Read our dividend analysis for RTO.

Is Rentokil Initial a good dividend stock?

Rentokil Initial (NYSE:RTO) pays an annual dividend of $0.56 per share and currently has a dividend yield of 1.40%.
Read our dividend analysis for RTO.

What is Rentokil Initial's stock symbol?

Rentokil Initial trades on the New York Stock Exchange (NYSE) under the ticker symbol "RTO."

Who are Rentokil Initial's major shareholders?

Rentokil Initial's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Gates Capital Management Inc. (1.05%), Brown Advisory Inc. (0.71%), Clearbridge Investments LLC (0.47%), Price T Rowe Associates Inc. MD (0.29%), Bank of New York Mellon Corp (0.19%) and Bank of America Corp DE (0.17%).

How do I buy shares of Rentokil Initial?

Shares of RTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rentokil Initial's stock price today?

One share of RTO stock can currently be purchased for approximately $40.76.

How much money does Rentokil Initial make?

Rentokil Initial (NYSE:RTO) has a market capitalization of $20.54 billion and generates $4.59 billion in revenue each year.

How can I contact Rentokil Initial?

Rentokil Initial's mailing address is Riverbank Meadows Business Park, Camberley X0, GU17 9AB. The official website for the company is www.rentokil-initial.com. The company can be reached via phone at 441293858000 or via email at investor@rentokil-initial.com.

This page (NYSE:RTO) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -